ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 186 filers reported holding ASCENDIS PHARMA A/S in Q4 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,016,000 | -6.0% | 7,445 | +4.2% | 0.00% | – |
Q1 2024 | $1,081,000 | +15.5% | 7,147 | -3.9% | 0.00% | – |
Q4 2023 | $936,000 | +45.8% | 7,435 | +8.3% | 0.00% | – |
Q3 2023 | $642,000 | -28.2% | 6,863 | -31.5% | 0.00% | – |
Q2 2023 | $894,000 | +735.5% | 10,013 | +901.3% | 0.00% | – |
Q1 2023 | $107,000 | -18.3% | 1,000 | -6.2% | 0.00% | – |
Q4 2022 | $131,000 | -15.5% | 1,066 | -29.1% | 0.00% | – |
Q3 2022 | $155,000 | -32.6% | 1,503 | -39.2% | 0.00% | – |
Q2 2022 | $230,000 | -18.1% | 2,474 | +3.6% | 0.00% | – |
Q1 2022 | $281,000 | +26.0% | 2,389 | +44.2% | 0.00% | – |
Q4 2021 | $223,000 | -35.4% | 1,657 | -23.5% | 0.00% | – |
Q3 2021 | $345,000 | +41.4% | 2,166 | +16.7% | 0.00% | – |
Q2 2021 | $244,000 | +5.6% | 1,856 | +3.9% | 0.00% | – |
Q1 2021 | $231,000 | -11.2% | 1,787 | +14.6% | 0.00% | – |
Q4 2020 | $260,000 | +31.3% | 1,560 | +21.6% | 0.00% | – |
Q3 2020 | $198,000 | +9.4% | 1,283 | +4.8% | 0.00% | – |
Q2 2020 | $181,000 | +79.2% | 1,224 | +36.0% | 0.00% | – |
Q1 2020 | $101,000 | -19.2% | 900 | 0.0% | 0.00% | – |
Q4 2019 | $125,000 | +42.0% | 900 | -1.6% | 0.00% | – |
Q3 2019 | $88,000 | -17.0% | 915 | 0.0% | 0.00% | – |
Q2 2019 | $106,000 | 0.0% | 915 | +1.7% | 0.00% | – |
Q1 2019 | $106,000 | +68.3% | 900 | -10.0% | 0.00% | – |
Q4 2018 | $63,000 | -11.3% | 1,000 | 0.0% | 0.00% | – |
Q3 2018 | $71,000 | – | 1,000 | +33233.3% | 0.00% | – |
Q2 2018 | $0 | – | 3 | -25.0% | 0.00% | – |
Q1 2018 | $0 | -100.0% | 4 | -78.9% | 0.00% | – |
Q4 2017 | $1,000 | – | 19 | +216.7% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 6 | -85.7% | 0.00% | – |
Q3 2015 | $1,000 | -66.7% | 42 | -77.0% | 0.00% | – |
Q2 2015 | $3,000 | – | 183 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |